期刊
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS
卷 52, 期 2, 页码 167-172出版社
ELSEVIER
DOI: 10.1016/j.jpba.2010.01.007
关键词
Dapivirine; HIV-1; Antiretroviral; Microbicides; RP-HPLC; Poly(lactic-co-glycolic acid); Nanoparticles
资金
- Fundacao para a Ciencia e a Tecnologia, Portugal [SFRH/BD/43393/2008]
- Fundação para a Ciência e a Tecnologia [SFRH/BD/43393/2008] Funding Source: FCT
The objective of this work was to develop and validate a rapid reversed-phase (RP) high-performance liquid chromatography (HPLC) method for the in vitro pharmaceutical characterization of dapivirine-loaded polymeric nanoparticles. Chromatographic runs were performed on a RP C18 column with a mobile phase comprising acetonitrile-0.5% (w/v) triethanolamine solution in isocratic mode (80:20, v/v) at a flow rate of 1 ml/min. Dapivirine was detected at a wavelength of 290 nm. The method was shown to be specific, linear in the range of 1-50 mu g/ml (R-2 =0.9998), precise at the intra-day and inter-day levels as reflected by the relative standard deviation values (less than 0.85%), accurate (recovery rate of 100.17 +/- 0.35%), and robust to changes in the mobile phase and column brand. The detection and quantitation limits were 0.08 and 0.24 mu g/ml, respectively. The method was successfully used to determine the loading capacity and association efficiency of dapivirine in poly(lactic-co-glycolic acid)-based nanoparticles and its in vitro release. (C) 2010 Elsevier B.V. All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据